Log in to save to my catalogue

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF co...

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF co...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb20517990ed4ee998a6eafe220aaf34

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry

About this item

Full title

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry

Publisher

England: BioMed Central

Journal title

Respiratory research, 2019-01, Vol.20 (1), p.16-16, Article 16

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the decline of lung function and overall survival (OS) in real-world cohorts on longer follow-up exists.
Of the enrolled Czech IPF patients (n = 841) from an EMPIRE registry, 383 (45.5%) received pi...

Alternative Titles

Full title

Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eb20517990ed4ee998a6eafe220aaf34

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb20517990ed4ee998a6eafe220aaf34

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X,1465-9921

DOI

10.1186/s12931-019-0977-2

How to access this item